Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Karsten Bruins Slot"'
Autor:
Paula Bousquet, Milena Blaga, Berit Nicolaisen, Karsten Bruins Slot, Agnete Fredriksen, Karoline Schjetne
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4de03328e4aec3f11a522951f70c487
https://doi.org/10.1136/jitc-2022-sitc2022.0669
https://doi.org/10.1136/jitc-2022-sitc2022.0669
Autor:
Peter Hillemanns, Kristina Lindemann, Jean-François Baurain, Pawel Blecharz, Karsten Bruins Slot, Karoline Schjetne, Siri Torhaug, Agnete Fredriksen
Publikováno v:
Cervical cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81692460d330326ccfc5d5d0d8bbc22c
https://doi.org/10.1136/ijgc-2022-esgo.26
https://doi.org/10.1136/ijgc-2022-esgo.26
Autor:
Stuart J. Pocock, Alexander R. Lyon, Daniel M. Bloomfield, Amany El-Gazayerly, Claudio Gimpelewicz, Faiez Zannad, Piotr Ponikowski, Warren Sherman, Fady I. Malik, Wendy Gattis Stough, Marco Metra, Anna Baczynska, Krishna Prasad, Karsten Bruins Slot, Caroline Boulton, Jose Lopez-Sendon, Pieter A. de Graeff, Maureen Cronin, Ian Laws, Isabelle Richard-Lordereau, Benoit Tyl, Karl Swedberg, Stefan D. Anker, Salim Janmohamed, Gerasimos Filippatos, Martin R. Cowie, Lothar Roessig, Heidi Janssen, Santiago Figueroa Perez, Martin Lefkowitz, Pieter A. Doevendans, Marc A. Pfeffer, Giuseppe M.C. Rosano, Narimon Honarpour, Maria Borentain, Albert M. Kim, Maria Angeles Alonso Garcia, John J.V. McMurray, Dominik Lautsch
Publikováno v:
European Journal of Heart Failure. 19:718-727
Despite the availability of a number of different classes of therapeutic agents with proven efficacy in heart failure, the clinical course of heart failure patients is characterized by a reduction in life expectancy, a progressive decline in health-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8f01ad99121884291aec9c2fad3ab50
https://doi.org/10.1002/ejhf.809
https://doi.org/10.1002/ejhf.809
Publikováno v:
Lindekleiv, H, Bruins Slot, K M H, Wardlaw, J M & Berge, E 2019, ' Percutaneous Vascular Interventions Versus Intravenous Thrombolytic Treatment for Acute Ischemic Stroke ', Stroke . https://doi.org/10.1161/STROKEAHA.118.024298
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95b31e25471e918d42dabfc592ed8755
https://hdl.handle.net/20.500.11820/ebb56f4f-171f-45fc-8f93-c1e246e931af
https://hdl.handle.net/20.500.11820/ebb56f4f-171f-45fc-8f93-c1e246e931af
Publikováno v:
The Cochrane Library
Background Most ischaemic strokes are caused by blockage of a cerebral artery by a thrombus. Intravenous administration of recombinant tissue plasminogen activator given within 4.5 hours is now standard treatment for this condition. Percutaneous vasc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c92e874ebd0b161fb6fde3ca0fc25a47
https://doi.org/10.1002/14651858.cd009292.pub2
https://doi.org/10.1002/14651858.cd009292.pub2
Autor:
Ian, Graham, Chuck, Shear, Pieter, De Graeff, Caroline, Boulton, Alberico L, Catapano, Wendy Gattis, Stough, Stefan C, Carlsson, Guy, De Backer, Joseph, Emmerich, Scott, Greenfeder, Albert M, Kim, Dominik, Lautsch, Tu, Nguyen, Steven E, Nissen, Krishna, Prasad, Kausik K, Ray, Jennifer G, Robinson, William J, Sasiela, Karsten, Bruins Slot, Erik, Stroes, Tom, Thuren, Bart, Van der Schueren, Maja, Velkovski-Rouyer, Scott M, Wasserman, Olov, Wiklund, Emmanouil, Zouridakis, Cathrine, Thorstensen
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy, 4(2). Oxford University Press
The very high occurrence of cardiovascular events presents a major public health issue because treatment remains suboptimal. Lowering low-density lipoprotein cholesterol (LDL-C) with statins or ezetimibe in combination with a statin reduces major adv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7cf81c7f2a5f838f13a85da28ee0952
https://doi.org/10.1093/ehjcvp/pvx031
https://doi.org/10.1093/ehjcvp/pvx031
Autor:
Jonas Bergh, Hege Thoresen, Tomas Salmonson, Ingunn Westgaard, Ronny Pieters, Kenneth Francis Hofland, Richard Sylvester, Venke Skibeli, Marianne Dalhus, Jens Ersbøll, Francesco Pignatti, Jeanett Borregaard, Kyriaki Tzogani, Karsten Bruins Slot, Gerald H. Mickisch, Per Damkier
Publikováno v:
The Oncologist. 20:196-201
Axitinib is a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 1 (VEGFR-1), VEGFR-2, and VEGFR-3. Based on the positive opinion from the European Medicines Agency (EMA), a marketing authorization valid throughout the European
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54c44f7d0c2934f3f10a69c5cf0ccfde
https://doi.org/10.1634/theoncologist.2014-0177
https://doi.org/10.1634/theoncologist.2014-0177
Autor:
John F. Forbes, Melinda B Roaldsen, Karsten Bruins Slot, Peter Sandercock, Jonathan Drever, Geoffrey Cohen, Joanna M. Wardlaw, Eva Isaksson, William Whiteley, Richard I. Lindley, Eivind Berge, Ann-Sofie Rudberg, Erik Lundström, Joel Smith
Publikováno v:
Berge, E, Cohen, G, Roaldsen, M B, Lundström, E, Isaksson, E, Rudberg, A-S, Slot, K B, Forbes, J, Smith, J, Drever, J, Wardlaw, J M, Lindley, R I & Sandercock, P A G & Whiteley, W N 2016, ' Effects of alteplase on survival after ischaemic stroke (IST-3) : 3 year follow-up of a randomised, controlled, open-label trial ', Lancet Neurology, vol. 15, no. 10, pp. 1028-1034 . https://doi.org/10.1016/S1474-4422(16)30139-9
Background: The effect of alteplase on patient survival after ischaemic stroke is the subject of debate. We report the effect of intravenous alteplase on long-term survival after ischaemic stroke of participants in the Third International Stroke Tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99b258d1e65dd3b3ffbb6214175af2f8
https://www.pure.ed.ac.uk/ws/files/25691802/Manuscript_text_and_tables_Track_changes_Off_160418.docx
https://www.pure.ed.ac.uk/ws/files/25691802/Manuscript_text_and_tables_Track_changes_Off_160418.docx
Autor:
Karsten Bruins Slot, Peter M Fernandes, William Whiteley, Peter Sandercock, Joanna M. Wardlaw
Publikováno v:
Stroke. 43:2904-2909
Background and Purpose— Recombinant tissue plasminogen activator (rtPA) is an effective treatment for acute ischemic stroke but is associated with an increased risk of intracranial hemorrhage (ICH). We sought to identify the risk factors for ICH wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d574338d8025339490dc4bfa8cce68
https://doi.org/10.1161/strokeaha.112.665331
https://doi.org/10.1161/strokeaha.112.665331
Publikováno v:
Slot, K B, Berge, E, Dorman, P, Lewis, S & Dennis, M & Sandercock, P 2008, ' Impact of functional status at six months on long term survival in patients with ischaemic stroke : prospective cohort studies ', British Medical Journal (BMJ), vol. 336, 376 . https://doi.org/10.1136/bmj.39456.688333.BE
Objective To estimate the impact on long term survival of functional status at six months after ischaemic stroke.Design Prospective cohort study.Settings Three cohorts: Oxfordshire community stroke project, Lothian stroke register, and the first inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4eff94890474ea25b2dae2596ba341
https://doi.org/10.1136/bmj.39456.688333.be
https://doi.org/10.1136/bmj.39456.688333.be